CASSAVA SCIENCES
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive.
CASSAVA SCIENCES
Industry:
Biopharma Biotechnology Life Science Medical Neuroscience Pharmaceutical
Founded:
1998-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.cassavasciences.com
Total Employee:
1+
Status:
Active
Contact:
(512) 501 - 2444
Total Funding:
206.9 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail ReCAPTCHA GoDaddy DNS ReCAPTCHA V2 Akamai Hosted Time Warner
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Nadav Friedmann Chief Medical Officer @ Cassava Sciences
Chief Medical Officer
Eric Schoen Chief Financial Officer @ Cassava Sciences
Chief Financial Officer
Remi Barbier Chairman of the Board, President & CEO /Founder @ Cassava Sciences
Chairman of the Board, President & CEO /Founder
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Cassava Sciences
National Institutes of Health
National Institutes of Health investment in Grant - Cassava Sciences
National Institutes of Health
National Institutes of Health investment in Grant - Cassava Sciences
Official Site Inspections
http://www.cassavasciences.com Semrush global rank: 1.51 M Semrush visits lastest month: 17.75 K
Unable to get host informations!!!
More informations about "Cassava Sciences"
Cassava Sciences - Wikipedia
Cassava Sciences was founded by Remi Barbier in May 1998 as Pain Therapeutics, [3] [4] focusing on opioids and chronic pain. [5] Barbier first heard of the research led by Stanley M. …See details»
Cassava Sciences Provides a Business Update - GlobeNewswire
Jan 7, 2025 “Cassava is a closely-knit organization, and so I want to thank each one of our employees being affected by this workforce reduction. ... media@cassavasciences.com. …See details»
Cassava Sciences, Inc. (SAVA) - Yahoo Finance Canada
Description . Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small …See details»
Cassava Sciences Provides a Business Update - Yahoo Finance
Jan 7, 2025 Topline data from Phase 3 REFOCUS-ALZ study of simufilam in patients with mild-to-moderate Alzheimer’s disease expected late first-quarter/early second-quarter 2025 …See details»
Cassava Sciences - Crunchbase Company Profile & Funding
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines.See details»
Cassava Sciences Org Chart + Executive Team - The Official Board
The organizational chart of Cassava Sciences displays its 15 main executives including Richard Barry, Eric Schoen and Michael O'DonnellSee details»
Cassava Sciences Appoints Three New Members to its Board of …
Dec 7, 2023 Anderson previously led more than 20,000 FBI employees as the bureau’s Executive Assistant Director of the Criminal, Cyber, Response and Services Branch— the No. …See details»
Cassava Sciences CEO and Key Executive Team | Craft.co
Cassava Sciences's Chairman of the Board, President & CEO is Remi Barbier. Other executives include Nadav Friedmann, Chief Medical Officer and Director; Richard J. Barry, Independent …See details»
Cassava Sciences Company Profile - Office Locations ... - Craft
Cassava Sciences (formerly known as Pain Therapeutics) is a clinical-stage biotechnology company that specializes in drug development. It offers preclinical development, clinical …See details»
Cassava Sciences Reports 2024 Financial Results and Provides …
Dec 31, 2024 For more information, please visit: https://www.CassavaSciences.com. For More Information Contact: Investors Sandya von der Weid svonderweid@lifesciadvisors.com. Media …See details»
Cassava Sciences Reports Full-year 2023 Financial Results and …
Dec 31, 2023 Premier Research International is the clinical research organization (CRO) supporting the conduct of our Phase 3 clinical program. ... (512) 501-2450 or …See details»
Cassava Sciences Appoints Freda Nassif as Chief Commercial
Nov 18, 2024 Freda Nassif, Chief Commercial Officer of Cassava commented, “I am honored to have the opportunity to lead the commercial organization for a novel therapy at a time in which …See details»
Cassava Sciences - 2025 Company Profile - Tracxn
Mar 14, 2025 Cassava Sciences - Developer of small molecule-based therapeutic solutions for treating neurological diseases. Public Company. Raised funding over 2 rounds from 2 …See details»
Cassava Sciences Inc Company Profile - Overview - GlobalData
Website www.cassavasciences.com Telephone 1 512 5012444. No of Employees 29. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange SAVA (NASD) EPS XYZ. Net …See details»
Cassava Sciences - Overview, News & Similar companies - ZoomInfo
Jul 16, 2024 Cassava Sciences has announced that the organization is searching for a Chief Executive Officer. Executive Moves, Seeking Replacement. ... (512) 501-2444 Website: …See details»
Cassava Sciences Appoints Three New Members to its Board of
Dec 7, 2023 Cassava Sciences, Inc., a clinical-stage biotechnology company focused on Alzheimer’s disease, announced the appointment of three new members to its Board of …See details»
Cassava Sciences Announces Initiation of Cognition Maintenance …
May 10, 2021 As of 2020, there were approximately 50 million people worldwide living with dementia, a figure expected to increase to 150 million by 2050. 1 The annual global cost of …See details»
Cassava Sciences, Inc. Company Overview, Contact Details
Nov 18, 2022 JDoe@cassavasciences.com: 38%. First@cassavasciences.com: John@cassavasciences.com: 12%. See more formats. Frequently Asked Questions Where is …See details»
Cassava Sciences Announces Significant Program Progress and …
AUSTIN, Texas, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates for Alzheimer’s …See details»
Eradicating Food Insecurity and Empowering Farmers One Crop at …
Mar 13, 2025 Between 2022 and 2025, CassVita has scaled from working with hundreds of cassava farmers to thousands. In discussing how the organization works with farmers in a way …See details»